Efficacy of caspofungin combined with trimethoprim/sulfamethoxazole as first‑line therapy to treat non‑HIV patients with severe pneumocystis pneumonia | |
Gensheng Zhang; Miaomiao Chen; Shufang Zhang; Hongwei Zhou; Xiaozhen Ji; Jiachang Cai; Tianzheng Lou; Wei Cui; Ning Zhang | |
刊名 | Experimental and Therapeutic Medicine |
2018 | |
卷号 | Vol.15 No.2页码:1594-1601 |
ISSN号 | 1792-0981;1792-1015 |
URL标识 | 查看原文 |
公开日期 | [db:dc_date_available] |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/5461857 |
专题 | 湖南大学 |
作者单位 | Department of Critical Care Medicine, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009, P.R. China, Department of Cardiology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009, P.R. China, Microbiology Laboratory, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009, P.R. China, Department of Critical Care Medicine, Longquan People's Hospital, Lishui, Zhejiang 323700, P.R. China, Department of Critical Care Medicine, Lishui People's Hospital, Lishui, Zhejiang 323000, P.R. China |
推荐引用方式 GB/T 7714 | Gensheng Zhang,Miaomiao Chen,Shufang Zhang,et al. Efficacy of caspofungin combined with trimethoprim/sulfamethoxazole as first‑line therapy to treat non‑HIV patients with severe pneumocystis pneumonia[J]. Experimental and Therapeutic Medicine,2018,Vol.15 No.2:1594-1601. |
APA | Gensheng Zhang.,Miaomiao Chen.,Shufang Zhang.,Hongwei Zhou.,Xiaozhen Ji.,...&Ning Zhang.(2018).Efficacy of caspofungin combined with trimethoprim/sulfamethoxazole as first‑line therapy to treat non‑HIV patients with severe pneumocystis pneumonia.Experimental and Therapeutic Medicine,Vol.15 No.2,1594-1601. |
MLA | Gensheng Zhang,et al."Efficacy of caspofungin combined with trimethoprim/sulfamethoxazole as first‑line therapy to treat non‑HIV patients with severe pneumocystis pneumonia".Experimental and Therapeutic Medicine Vol.15 No.2(2018):1594-1601. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论